RAPT Therapeutics, Inc. (RAPT)

NASDAQ: RAPT · Real-Time Price · USD

Compare

57.74

-0.03 (-0.05%)

At close: Feb 10, 2026, 4:00 PM EST

57.70

-0.04 (-0.07%)

After-hours: Feb 10, 2026, 5:12 PM EST

RAPT Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	37.93	169.74	47.48	38.95	24.03	24.92
Short-Term Investments	119.41	61.32	111.38	210.12	165.63	86.59
Cash & Short-Term Investments	157.34	231.06	158.86	249.07	189.65	111.51
Cash Growth	60.71%	45.44%	-36.22%	31.33%	70.08%	44.10%
Prepaid Expenses	3.7	4.18	2.92	3.63	3.32	4.09
Total Current Assets	161.05	235.24	161.78	252.69	192.97	115.6
Property, Plant & Equipment	2.65	4.7	7.68	9.48	2.74	2.98
Other Long-Term Assets	2.05	0.39	3.87	4.04	2.92	0.39
Total Assets	165.74	240.33	173.33	266.21	198.64	118.97
Accounts Payable	2.1	1.28	5.18	3.37	2	2.38
Accrued Expenses	9.01	44.6	14.1	8.66	6.33	4.94
Current Portion of Leases	2.21	2.42	2.45	2.17	-	-
Current Unearned Revenue	-	-	-	-	1.02	4.1
Other Current Liabilities	0.06	0.06	0.11	0.03	0.25	0.33
Total Current Liabilities	13.38	48.35	21.84	14.22	9.6	11.74
Long-Term Leases	0.39	2.07	4.46	6.82	-	-
Long-Term Unearned Revenue	-	-	-	-	0.51	0.86
Other Long-Term Liabilities	-	-	-	-	2.15	2.19
Total Liabilities	13.76	50.42	26.29	21.04	12.26	14.79
Common Stock	0	0.01	0	0	0	0
Additional Paid-In Capital	818.81	804.39	631.61	613.07	470.63	319.2
Retained Earnings	-666.94	-614.55	-484.68	-367.88	-284.05	-214.84
Comprehensive Income & Other	0.1	0.05	0.1	-0.03	-0.21	-0.18
Total Common Equity	151.98	189.9	147.04	245.17	186.38	104.18
Shareholders' Equity	151.98	189.9	147.04	245.17	186.38	104.18
Total Liabilities & Equity	165.74	240.33	173.33	266.21	198.64	118.97
Total Debt	2.6	4.49	6.91	8.99	-	-
Net Cash (Debt)	154.75	226.56	151.96	240.08	189.65	111.51
Net Cash Growth	66.78%	49.10%	-36.71%	26.59%	70.08%	44.10%
Net Cash Per Share	7.14	44.47	31.71	59.02	55.39	36.96
Filing Date Shares Outstanding	27.71	16.5	4.35	4.29	3.7	3.11
Total Common Shares Outstanding	16.86	16.5	4.3	4.28	3.69	3.1
Working Capital	147.67	186.89	139.95	238.47	183.38	103.86
Book Value Per Share	9.02	11.51	34.20	57.26	50.45	33.64
Tangible Book Value	151.98	189.9	147.04	245.17	186.38	104.18
Tangible Book Value Per Share	9.02	11.51	34.20	57.26	50.45	33.64
Machinery	7.85	8.15	8.52	7.49	7.13	6.77
Leasehold Improvements	3.3	3.3	3.3	3.3	3.3	3.29

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q